News

• New diabetes guides
• Published on Apr 05, 2010

NHS Diabetes (www.diabetes. nhs.uk) has published six new guides to support clinicians and patients with diabetes.

• Commons committee on dementia management
• Published on Apr 05, 2010

There is still inequality between regions in access to drug treatment for dementia and too much antipsychotic prescribing for patients with dementia, says the House of Commons Committee of Public Accounts.

• Warn MS patients on natalizumab about PML
• Published on Apr 05, 2010

Patients with multiple sclerosis considering treatment with natalizumab (Tysabri) should be warned of the risk of progressive multifocal leuco­encephalopathy (PML) before starting therapy and again after two years, the MHRA states in its latest Drug Safety Update (2010;3, Issue 8).

• Self-monitoring advised for sulphonylureas
• Published on Apr 05, 2010

Patients with type 2 diabetes treated with a sulphonylurea should be offered self-monitoring of blood glucose to enable them to identify hypoglycaemic episodes, according to a new report by NHS Diabetes (www.diabetes. nhs.uk).

• Sibutramine suspension sets new standard
• Published on Feb 19, 2010

By suspending the licence for sibutramine (Reductil), the European Medicines Agency has established a high standard for the balance of efficacy and safety for weight-loss drugs.